{"url":"https://lda.senate.gov/api/v1/filings/69a43a13-e2d1-4f3e-b3f9-a9cd15bd32b3/","filing_uuid":"69a43a13-e2d1-4f3e-b3f9-a9cd15bd32b3","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2024,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/69a43a13-e2d1-4f3e-b3f9-a9cd15bd32b3/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kat Murti","dt_posted":"2024-04-05T09:49:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2370 Champlain St NW ste 12","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20009","registrant":{"id":401105102,"url":"https://lda.senate.gov/api/v1/registrants/401105102/","house_registrant_id":null,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","description":"Drug policy reform advocacy","address_1":"2370 Champlain St NW ste 12","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20009","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KAT MURTI","contact_telephone":"+1 214-542-4056","dt_updated":"2026-07-14T21:09:50.477507-04:00"},"client":{"id":212030,"url":"https://lda.senate.gov/api/v1/clients/212030/","client_id":12,"name":"STUDENTS FOR SENSIBLE DRUG POLICY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-07-01"},"lobbying_activities":[{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Cannabis legalization and retroactive justice Psychedelic therapy & research Ending the War on Drugs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":"Executive Director","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Ending the War on Drugs Controlled Substance Act Scheduling","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145692,"prefix":null,"prefix_display":null,"first_name":"KAT","nickname":null,"middle_name":null,"last_name":"MURTI","suffix":null,"suffix_display":null},"covered_position":"Executive Director","new":true}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}